Pharmaceutical Fronts

Aims & Scope

Pharmaceutical Fronts is an international peer-reviewed journal focusing on the rapid and high-quality dissemination of the latest breakthroughs in pharmaceutical development across major scientific and engineering disciplines.

It is an affiliated journal of the Chinese Journal of Pharmaceuticals (EI Compendex), which was founded in 1970, and sponsored by Shanghai Institute of Pharmaceutical Industry, Chinese Pharmaceutical Association and China Pharmaceutical Industry Association.

The journal is delivering the ultimate reader experience with an innovative manuscript acquisition and review process focusing on information density, utility, and reliability.

Its aims to cover original research as well as high quality reviews in medicinal chemistry, process development, and technological innovations for both laboratory and production settings.

We will remain agile towards reader feedback and seek to provide a unique service to the global scientific and industrial community in the quest for better medicines and better ways to make them for patients across the world.

Publishing 4 times a year in March, June, September, and December, Pharmaceutical Fronts includes significant original research articles as well as high quality reviews, commentaries and short communications in the following areas: Drug & Synthesis Technology- Asymmetric Catalysis and Green Chemistry- Medicinal Chemistry- Biopharmaceuticals- Pharmaceutical Sciences and Formulation Technology- Analytical Sciences- Engineering Innovations- Process Safety and Regulatory Sciences

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Preservation url
• Apc url
• License

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Factors Influencing the Green Synthesis of Metallic Nanoparticles Using Plant Extracts: A Comprehensive Review

  Citation: 66

  Authors: Aisha, Hajra, Faisal, Muhammad

• Current Advances in Sustained Release Microneedles

  Citation: 42

  Authors: Guangsheng, Xun

• Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation

  Citation: 33

  Authors: Guan, Jin, Xiao-Li, Fa-Qian, Yu-Meng, Ao-Xue, Liang

• Immunotoxins: Targeted Toxin Delivery for Cancer Therapy

  Citation: 21

  Authors: Xin, Junsheng, Jing, Jianwei

• Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

  Citation: 20

  Authors: Yan-Qi, Li-Jun, Er-Fen, Jiang-Yue, Ying, Lin-Miao, Xin-Xin

• Metal Complexes as DNA Synthesis and/or Repair Inhibitors: Anticancer and Antimicrobial Agents

  Citation: 18

  Authors: Mpho Phehello, Hadley S.

• Natural Occurrence, Biological Functions, and Analysis of D-Amino Acids

  Citation: 16

  Authors: Shuang-Xi, Hai-Feng, Yuan-Yuan, Fen-Er

• Application of Chiral Piperidine Scaffolds in Drug Design

  Citation: 14

  Authors: Qiu-Shi, Jian-Qi, Qing-Wei

• Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development

  Citation: 12

  Authors: Sharmin Reza, Fangzhou, Jinxin, Lei

• Molecular Docking, Drug-Likeness Analysis, In Silico Pharmacokinetics, and Toxicity Studies of p-Nitrophenyl Hydrazones as Anti-inflammatory Compounds against COX-2, 5-LOX, and H+/K+ ATPase

  Citation: 11

  Authors: Sodeeq, Nosakhare, Isaiah